Your browser doesn't support javascript.
loading
In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4+ T-Cells.
Bissa, Massimiliano; Galli, Veronica; Schifanella, Luca; Vaccari, Monica; Rahman, Mohammad Arif; Gorini, Giacomo; Binello, Nicolò; Sarkis, Sarkis; Gutowska, Anna; Silva de Castro, Isabela; Doster, Melvin N; Moles, Ramona; Ferrari, Guido; Shen, Xiaoying; Tomaras, Georgia D; Montefiori, David C; N'guessan, Kombo F; Paquin-Proulx, Dominic; Kozlowski, Pamela A; Venzon, David J; Choo-Wosoba, Hyoyoung; Breed, Matthew W; Kramer, Joshua; Franchini, Genoveffa.
Afiliação
  • Bissa M; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
  • Galli V; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
  • Schifanella L; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
  • Vaccari M; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
  • Rahman MA; Tulane National Primate Center & School of Medicine, Tulane University, Covington, LA 70118, USA.
  • Gorini G; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
  • Binello N; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
  • Sarkis S; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
  • Gutowska A; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
  • Silva de Castro I; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
  • Doster MN; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
  • Moles R; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
  • Ferrari G; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
  • Shen X; Division of Surgical Sciences, Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.
  • Tomaras GD; Division of Surgical Sciences, Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.
  • Montefiori DC; Division of Surgical Sciences, Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.
  • N'guessan KF; Division of Surgical Sciences, Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.
  • Paquin-Proulx D; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
  • Kozlowski PA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
  • Venzon DJ; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
  • Choo-Wosoba H; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
  • Breed MW; Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
  • Kramer J; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
  • Franchini G; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Vaccines (Basel) ; 11(11)2023 Oct 30.
Article em En | MEDLINE | ID: mdl-38005994

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article